How effective is Eldepryl for Parkinson's Disease? (a real world drug study)
Summary:
Overall ratings: 3.3/5 Long term ratings: 3.5/5
This is a phase IV clinical study of how effective Eldepryl (selegiline hydrochloride) is for Parkinson's disease and for what kind of people. The study is created by eHealthMe from 3 Eldepryl users and is updated continuously.
What is Eldepryl?
Eldepryl has active ingredients of selegiline hydrochloride. It is often used in parkinson's disease. eHealthMe is studying from 752 Eldepryl users. Check the latest studies of Eldepryl.
What is Parkinson's disease?
Parkinson's disease is found to be associated with 1,115 drugs and 1,625 conditions by eHealthMe. Check the latest studies of Parkinson's disease.
3 people are studied for taking Eldepryl in Parkinson's disease
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Eldepryl effectiveness for Parkinson's disease (number of people):
Overall:
- not at all: 0
- somewhat: 0
- moderate: 2
- high: 1
- very high: 0
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 1
- high: 1
- very high: 0
Gender of people who take Eldepryl for Parkinson's disease *:
- female: 66.67 %
- male: 33.33 %
Age of people who take Eldepryl for Parkinson's disease *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 66.67 %
- 60+: 33.33 %
Who find Eldepryl more effective for Parkinson's Disease?
Gender of people who take Eldepryl for Parkinson's disease *:
- female: 100 %
- male: 0.0 %
Age of people who take Eldepryl for Parkinson's disease *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 100 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Eldepryl?
- You can start a phase IV clinical trial to monitor Eldepryl safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Woulfe JM, Gray MT, Gray DA, Munoz DG, Middeldorp JM, "Hypothesis: a role for EBV-induced molecular mimicry in Parkinson's disease", Parkinsonism & related disorders, 2014 Jul .
- Woulfe JM, Gray MT, Gray DA, Munoz DG, Middeldorp JM, "Hypothesis: a role for EBV-induced molecular mimicry in Parkinson's disease", Parkinsonism & related disorders, 2014 Jul .
Related studies
Alternative drugs to, pros and cons of:
- Eldepryl (752 reports)
Treatments, associated drugs and conditions:
- Parkinson's disease (151,258 reports)
How the study uses the data?
The study is based on selegiline hydrochloride (the active ingredients of Eldepryl) and Eldepryl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Leustatin vs. Cholestyramine Light, side effect and effectiveness comparison - 6 seconds ago
- Drug interactions of Clozapine and Oxycodone - 7 seconds ago
- Drug interactions of Diclofenac Potassium and Methylprednisolone Sodium Succinate - 8 seconds ago
- Could Besivance cause Vitreous Floaters? - 14 seconds ago
- Could Creon cause Biliary Sepsis? - 15 seconds ago
- Diabetes and Hyphaema - 20 seconds ago
- Drug interactions of Entresto and Basaglar - 27 seconds ago
- Could Doxil cause Hypokinesia? - 29 seconds ago
- Drug interactions of Mycostatin and Ambien - 31 seconds ago
- Could Clonidine cause Muscle Spasticity? - 32 seconds ago